Gilead (GILD) Could Unleash Massive Accelerated Repurchase, Suggests RBC Capital
Tweet Send to a Friend
RBC Capital maintained an Outperform rating on Gilead Sciences (NASDAQ: GILD) with a price target of $125. The stock declined ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
